United States Anti-Peptic Ulcer Drugs Market Report & Forecast 2021-2027

Publisher Name :
Date: 08-Sep-2021
No. of pages: 91
Inquire Before Buying

United States Anti-Peptic Ulcer Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Anti-Peptic Ulcer Drugs Market Segment Percentages, By Type, 2020 (%)

- Proton Pump Inhibitors (PPIs)

- Potassium-Competitive Acid Blockers (P-CAB)

- Antacids

- H2 Antagonists

- Ulcer Protective Drugs

United States Anti-Peptic Ulcer Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Anti-Peptic Ulcer Drugs Market Segment Percentages, By Application, 2020 (%)

- Gastritis

- Gastric Ulcers

- Duodenal Ulcers

- Gastroesophageal Reflux Disease (GERD)

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Peptic Ulcer Drugs revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Anti-Peptic Ulcer Drugs revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- AstraZeneca

- Ask-pharm

- Takeda

- Yangtze River Pharm

- Shandong Luoxin

- Huadong Medicine

- Changzhou Siyao

- Beijing Yuekang

- Guangdong Dahua

- Xian Janssen

United States Anti-Peptic Ulcer Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Anti-Peptic Ulcer Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Anti-Peptic Ulcer Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Anti-Peptic Ulcer Drugs Overall Market Size
2.1 United States Anti-Peptic Ulcer Drugs Market Size: 2021 VS 2027
2.2 United States Anti-Peptic Ulcer Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Peptic Ulcer Drugs Players in United States Market
3.2 Top United States Anti-Peptic Ulcer Drugs Companies Ranked by Revenue
3.3 United States Anti-Peptic Ulcer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-Peptic Ulcer Drugs Companies in United States Market, by Revenue in 2020
3.5 Companies Anti-Peptic Ulcer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Players in United States Market
3.6.1 List of Tier 1 Anti-Peptic Ulcer Drugs Companies in United States
3.6.2 List of Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Anti-Peptic Ulcer Drugs Market Size Markets, 2021 & 2027
4.1.2 Proton Pump Inhibitors (PPIs)
4.1.3 Potassium-Competitive Acid Blockers (P-CAB)
4.1.4 Antacids
4.1.5 H2 Antagonists
4.1.6 Ulcer Protective Drugs
4.2 By Type - United States Anti-Peptic Ulcer Drugs Revenue & Forecasts
4.2.1 By Type - United States Anti-Peptic Ulcer Drugs Revenue, 2016-2021
4.2.2 By Type - United States Anti-Peptic Ulcer Drugs Revenue, 2022-2027
4.2.3 By Type - United States Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Anti-Peptic Ulcer Drugs Market Size, 2021 & 2027
5.1.2 Gastritis
5.1.3 Gastric Ulcers
5.1.4 Duodenal Ulcers
5.1.5 Gastroesophageal Reflux Disease (GERD)
5.2 By Application - United States Anti-Peptic Ulcer Drugs Revenue & Forecasts
5.2.1 By Application - United States Anti-Peptic Ulcer Drugs Revenue, 2016-2021
5.2.2 By Application - United States Anti-Peptic Ulcer Drugs Revenue, 2022-2027
5.2.3 By Application - United States Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
6 Anti-Peptic Ulcer Drugs Companies Profiles
6.1 AstraZeneca
6.1.1 AstraZeneca Company Details
6.1.2 AstraZeneca Business Overview
6.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Introduction
6.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.1.5 AstraZeneca Recent Developments
6.2 Ask-pharm
6.2.1 Ask-pharm Company Details
6.2.2 Ask-pharm Business Overview
6.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Introduction
6.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.2.5 Ask-pharm Recent Developments
6.3 Takeda
6.3.1 Takeda Company Details
6.3.2 Takeda Business Overview
6.3.3 Takeda Anti-Peptic Ulcer Drugs Introduction
6.3.4 Takeda Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.3.5 Takeda Recent Developments
6.4 Yangtze River Pharm
6.4.1 Yangtze River Pharm Company Details
6.4.2 Yangtze River Pharm Business Overview
6.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Introduction
6.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.4.5 Yangtze River Pharm Recent Developments
6.5 Shandong Luoxin
6.5.1 Shandong Luoxin Company Details
6.5.2 Shandong Luoxin Business Overview
6.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Introduction
6.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.5.5 Shandong Luoxin Recent Developments
6.6 Huadong Medicine
6.6.1 Huadong Medicine Company Details
6.6.2 Huadong Medicine Business Overview
6.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Introduction
6.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.6.5 Huadong Medicine Recent Developments
6.7 Changzhou Siyao
6.7.1 Changzhou Siyao Company Details
6.7.2 Changzhou Siyao Business Overview
6.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Introduction
6.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.7.5 Changzhou Siyao Recent Developments
6.8 Beijing Yuekang
6.8.1 Beijing Yuekang Company Details
6.8.2 Beijing Yuekang Business Overview
6.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Introduction
6.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.8.5 Beijing Yuekang Recent Developments
6.9 Guangdong Dahua
6.9.1 Guangdong Dahua Company Details
6.9.2 Guangdong Dahua Business Overview
6.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Introduction
6.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.9.5 Guangdong Dahua Recent Developments
6.10 Xian Janssen
6.10.1 Xian Janssen Company Details
6.10.2 Xian Janssen Business Overview
6.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Introduction
6.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021)
6.10.5 Xian Janssen Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Anti-Peptic Ulcer Drugs Market Opportunities & Trends in United States Market
Table 2. Anti-Peptic Ulcer Drugs Market Drivers in United States Market
Table 3. Anti-Peptic Ulcer Drugs Market Restraints in United States Market
Table 4. Key Players of Anti-Peptic Ulcer Drugs in United States Market
Table 5. Top Anti-Peptic Ulcer Drugs Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Anti-Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Anti-Peptic Ulcer Drugs Revenue Share by Companies, 2016-2021
Table 8. Companies Anti-Peptic Ulcer Drugs Product Type
Table 9. List of Tier 1 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2022-2027
Table 17. AstraZeneca Company Details
Table 18. AstraZeneca Business Overview
Table 19. AstraZeneca Anti-Peptic Ulcer Drugs Product
Table 20. AstraZeneca Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. AstraZeneca Recent Developments
Table 22. Ask-pharm Company Details
Table 23. Ask-pharm Business Overview
Table 24. Ask-pharm Anti-Peptic Ulcer Drugs Product
Table 25. Ask-pharm Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Ask-pharm Recent Developments
Table 27. Takeda Company Details
Table 28. Takeda Business Overview
Table 29. Takeda Anti-Peptic Ulcer Drugs Product
Table 30. Takeda Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Takeda Recent Developments
Table 32. Yangtze River Pharm Company Details
Table 33. Yangtze River Pharm Business Overview
Table 34. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
Table 35. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Yangtze River Pharm Recent Developments
Table 37. Shandong Luoxin Company Details
Table 38. Shandong Luoxin Business Overview
Table 39. Shandong Luoxin Anti-Peptic Ulcer Drugs Product
Table 40. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Shandong Luoxin Recent Developments
Table 42. Huadong Medicine Company Details
Table 43. Huadong Medicine Business Overview
Table 44. Huadong Medicine Anti-Peptic Ulcer Drugs Product
Table 45. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Huadong Medicine Recent Developments
Table 47. Changzhou Siyao Company Details
Table 48. Changzhou Siyao Business Overview
Table 49. Changzhou Siyao Anti-Peptic Ulcer Drugs Product
Table 50. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Changzhou Siyao Recent Developments
Table 52. Beijing Yuekang Company Details
Table 53. Beijing Yuekang Business Overview
Table 54. Beijing Yuekang Anti-Peptic Ulcer Drugs Product
Table 55. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Beijing Yuekang Recent Developments
Table 57. Guangdong Dahua Company Details
Table 58. Guangdong Dahua Business Overview
Table 59. Guangdong Dahua Anti-Peptic Ulcer Drugs Product
Table 60. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Guangdong Dahua Recent Developments
Table 62. Xian Janssen Company Details
Table 63. Xian Janssen Business Overview
Table 64. Xian Janssen Anti-Peptic Ulcer Drugs Product
Table 65. Xian Janssen Anti-Peptic Ulcer Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Xian Janssen Recent Developments
List of Figures
Figure 1. Anti-Peptic Ulcer Drugs Segment by Type
Figure 2. Anti-Peptic Ulcer Drugs Segment by Application
Figure 3. United States Anti-Peptic Ulcer Drugs Market Overview: 2020
Figure 4. United States Anti-Peptic Ulcer Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Anti-Peptic Ulcer Drugs Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Anti-Peptic Ulcer Drugs Revenue in 2020
Figure 7. By Type - United States Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
Figure 8. By Application - United States Anti-Peptic Ulcer Drugs Revenue Market Share, 2016-2027
Figure 9. AstraZeneca Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Ask-pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Takeda Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Xian Janssen Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs